← Back
Data updated: Jun 28, 2026
POWDER PHARMS
Pharma Pharmaceuticals
POWDER PHARMS is a pharmaceutical company with 1 FDA-approved products.
2007
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Small Molecules
POWDER PHARMS's Key Drugs
POWDER PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
POWDER PHARMS's Recent FDA Approvals
New NDA/BLA approvals for POWDER PHARMS over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
POWDER PHARMS's Therapeutic Areas
Disease areas where POWDER PHARMS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
POWDER PHARMS Pipeline Snapshot
Active clinical trials for POWDER PHARMS across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2007-08-16
- Latest
- 2025-12-19
- Applications
- 1